Active Clinical Trials - Bone Marrow Transplant

OVPR SiteMap | Temple Home | Graduate Programs | Graduate Schools at Temple

Active Clinical Trials

Bone Marrow Transplant

For more information regarding the Bone Marrow Transplant Program at Temple University Visit the Home Page by Clicking here

Department: Bone Marrow Transplant	Condition: (as stated in title) Multiple Myeloma - Prevention of Nausea and Vomiting	PI Name: Mangan, Kenneth	IRB #: 10079
A double blind phase II Study to assess the safety and efficacy of aloxi (palonosetron HCL) for the prevention of nausea and vomiting in multiple myeloma patients receiving high dose melphalan as conditioning chemotherapy for stem cell transplantation
IRB Approval Valid Through: 15-Jan-2009
Status of Trial: Open to Recruitment

Department: Bone Marrow Transplant	Condition: (as stated in title) Hematologic Malignancies	PI Name: Mangan, Kenneth	IRB #: 10179
A Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Plaifermin (rHuKGF) in the Reducation of Acute Graft Versus Host Disease in Subjects wtih Hematologic Malignancies Undergoing Allogenic Marrow/PBPC Transplantation
IRB Approval Valid Through: 15-Jan-2009
Status of Trial: Open to Recruitment

Department: Bone Marrow Transplant	Condition: (as stated in title) Oral Mucositis	PI Name: Mangan, Kenneth	IRB #: 10635
A Phase II Randomized Double-Blind Placebo Controlled Trial to Assess Safety and Efficacy of Velafermin for Prevention of Oral Mucositis in Hematologic Cancer Patients receiving Autologous Stem Cell Transplant
IRB Approval Valid Through: 15-Jan-2009
Status of Trial: Ongoing: not open to the recruitment of new subjects

Department: Bone Marrow Transplant	Condition: (as stated in title) Chronic Myeloid Leukemia (CML)	PI Name: Emmons, Robert	IRB #: 11337
A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) with the T3151 BCR-ABL Gene Mutation (CGX 635-CML-202)
IRB Approval Valid Through: 10-Dec-2008
Status of Trial: Open to Recruitment

Department: Bone Marrow Transplant	Condition: (as stated in title) Chronic Myeloid Leukemia (CML)	PI Name: Emmons, Robert	IRB #: 11338
A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) Who have failed or are intolerant to Tyrosine Kinase Inhibitor Therapy (CGX-6350CML-203)
IRB Approval Valid Through: 12-Dec-2008
Status of Trial: Open to Recruitment

Department: Bone Marrow Transplant	Condition: (as stated in title) Acute Myeloid Leukemia (AML)	PI Name: Emmons, Robert	IRB #: 11426
A Phase II Study of Allogeneic Transplant for Older Patients with AML in First Morphologic Complete Remission Using a Non-Myeloablative Preparative Regimen
IRB Approval Valid Through: 21-Jan-2009
Status of Trial: Open to Recruitment

Department: Bone Marrow Transplant	Condition: (as stated in title) Multiple Myeloma	PI Name: Emmons, Robert	IRB #: 10375
A Phase III Randomized, Double-Blind Study of Maintenance Therapy with CC-5013 or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
IRB Approval Valid Through: 16-Jun-2008
Status of Trial: Open to Recruitment

Department: Bone Marrow Transplant	Condition: (as stated in title) Renal Cell Carcinoma	PI Name: Mangan, Kenneth	IRB #: 10080
Multicenter Phase II study of nonmyeloablative allogenic stem cell transplantation using matched unrelated donor for metastatic renal cell carcinoma
IRB Approval Valid Through: 12-Dec-2008
Status of Trial: Ongoing- not open to the recruitment of new subjects

Email: Webmaster © Copyright 2003,Temple University. All rights reserved. Temple University web disclaimer